Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target.
Mun DG, Jessen E, Tomlinson JL, Carlson D, Budhraja R, Alva-Ruiz R, Abdelrahman A, Watkins R, Gregory L, McCabe C, Wang C, Graham RP, Woods K, Golkowski M, Baker M, Gores GJ, Ilyas SI, Conboy C, Larson EL, Sample JW, Ozmert EH, Kandasamy RK, Borad MJ, Roberts L, Andersen J, Pandey A, Smoot RL.
Mun DG, et al. Among authors: golkowski m.
Hepatology. 2026 Aug 1;84(2):396-410. doi: 10.1097/HEP.0000000000001535. Epub 2025 Sep 29.
Hepatology. 2026.
PMID: 41020779
Free PMC article.